Article Text

Download PDFPDF
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
  1. G Montalescot1,
  2. H R Andersen2,
  3. D Antoniucci3,
  4. A Betriu4,
  5. M J de Boer5,
  6. L Grip6,
  7. F J Neumann7,
  8. M T Rothman8
  1. 1Centre Hospitalier Universitaire Pitié-Salpétrière, Paris, France
  2. 2Skejby University Hospital, Aarhus, Denmark
  3. 3Ospedale Careggi, Firenze, Italy
  4. 4Hospital Clinico, Barcelona, Spain
  5. 5Isala Klinieken, Zwolle, The Netherlands
  6. 6Sahlgrenska University Hospital, Göteborg, Sweden
  7. 7Herzzentrum Bad Krozingen, Bad Krozingen, Germany
  8. 8The London Chest Hospital, London, UK
  1. Correspondence to:
    Dr G Montalescot
    Institut de Cardiologie, Bureau 2-236, Centre Hospitalier Universitaire Pitié-Salpétrière, 47 Bl de l’Hôpital, 75013 Paris, France;


Little information is currently available from the various societies of cardiology on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Since primary PCI is the main method of reperfusion in AMI in many centres, and since of all cardiac emergencies AMI represents the most urgent situation for PCI, recommendations based on scientific evidence and expert experience would be useful for centres practising primary PCI, or those looking to establish a primary PCI programme. To this aim, a task force for primary PCI in AMI was formed to develop a set of recommendations to complement and assist clinical judgment. This paper represents the product of their recommendations.

  • percutaneous coronary intervention
  • acute myocardial infarction
  • ACT, activated clotting time
  • ACC, American College of Cardiology
  • AHA, American Heart Association
  • ACE, angiotensin converting enzyme
  • AMI, acute myocardial infarction
  • CABG, coronary artery bypass graft
  • ERV, emergency revascularisation
  • Gp, glycoprotein
  • IMS, initial medical stabilisation
  • IABP, intra-aortic balloon pump
  • LV, left ventricular
  • LVEF, left ventricular ejection fraction
  • LMWH, low molecular weight heparin
  • MI, myocardial infarction
  • PCI, percutaneous coronary intervention
  • PTCA, percutaneous transluminal coronary angioplasty
  • POBA, plain old balloon angioplasty
  • SVG, saphenous vein graft
  • TVR, target vessel revascularisation
  • t-PA, tissue plasminogen activator
  • UFH, unfractionated heparin

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • This task force was supported by an unrestricted educational grant from Eli Lilly and Company.